Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Fresenius Kabi USA, LLC recalls Tyenne (tocilizumab-aazg) Injection

Class Iofficial

FDA Class I

FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.

Hazard
Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
Products
  • Tyenne (tocilizumab-aazg) Injection
Where it was sold

Nationwide in the USA

Nationwide

Units affected
4,643 20mL-vials
About this recall
Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC 65219-594-20.